Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Clinical trial NCT06449222 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06449222
Sponsor: BioNTech SE
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Breast Cancer Triple Negative Breast Cancer Metastatic Triple Negative Breast Cancers

Start date: 2024-08-26
Primary completion: 2028-08-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.